Citation 143086
ZHU,M: BOWERY,NG: GREENGRASS,PM: PHILLIPSON,JD:. (1996). APPLICATION OF RADIOLIGAND RECEPTOR BINDING ASSAYS IN THE SEARCH FOR CNS ACTIVE PRINCIPLES FROM CHINESE MEDICINAL PLANTS.. 54(2/3)
Citation Details
| Title | APPLICATION OF RADIOLIGAND RECEPTOR BINDING ASSAYS IN THE SEARCH FOR CNS ACTIVE PRINCIPLES FROM CHINESE MEDICINAL PLANTS. |
|---|---|
| Authors | ZHU,M: BOWERY,NG: GREENGRASS,PM: PHILLIPSON,JD: |
| Year | 1996 |
| Volume | 54 |
| Issue | 2/3 |
Summary
Year: 1996
Journal: Unknown
Organisms and Their Experiments (13)
Schefflera bodinieri (ARALIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
WEAK ACTIVITY
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
ACTIVE
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
ACTIVE
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
STRONG ACTIVITY
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
STRONG ACTIVITY
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
STRONG ACTIVITY
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
WEAK ACTIVITY
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
Schefflera bodinieri (ARALIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
WEAK ACTIVITY
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
ACTIVE
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
WEAK ACTIVITY
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
STRONG ACTIVITY
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
Schefflera delavayi (ARALIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
NOT POSSIBLE TO INTERPRET RESULTS
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
INACTIVE
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
INACTIVE
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
ACTIVE
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
ACTIVE
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
Schefflera delavayi (ARALIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
INACTIVE
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
INACTIVE
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
ACTIVE
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
ACTIVE
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
STRONG ACTIVITY
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
STRONG ACTIVITY
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
INACTIVE
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
Schefflera delavayi (ARALIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
INACTIVE
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 9 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 10 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
INACTIVE
|
|
| 11 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
ACTIVE
|
|
| 12 |
CALCIUM CHANNEL BINDING EFFECT
| None |
ACTIVE
|
|
| 13 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
STRONG ACTIVITY
|
|
| 15 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 16 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 17 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
Celastrus angulatus (CELASTRACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
INACTIVE
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
INACTIVE
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
ACTIVE
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
EQUIVOCAL
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
EQUIVOCAL
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
ACTIVE
|
|
| 18 |
ANGIOTENSIN-II INHIBITION
| None |
STRONG ACTIVITY
|
|
| 19 |
ANGIOTENSIN-II INHIBITION
| None |
ACTIVE
|
Celastrus orbiculatus (CELASTRACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
INACTIVE
|
|
| 5 |
CA PUMP INHIBITION
| None |
EQUIVOCAL
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
WEAK ACTIVITY
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
INACTIVE
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
WEAK ACTIVITY
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
WEAK ACTIVITY
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
EQUIVOCAL
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
EQUIVOCAL
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
EQUIVOCAL
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
INACTIVE
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
INACTIVE
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
Clerodendrum mandarinorum (VERBENACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
EQUIVOCAL
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
ACTIVE
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
WEAK ACTIVITY
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
Clerodendrum bungei (VERBENACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
INACTIVE
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
ACTIVE
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
EQUIVOCAL
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
ACTIVE
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
STRONG ACTIVITY
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
STRONG ACTIVITY
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 19 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 20 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 21 |
GABA RECEPTOR BLOCKING EFFECT
| None |
WEAK ACTIVITY
|
|
| 22 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
Periploca calophylla (ASCLEPIADACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
INACTIVE
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
WEAK ACTIVITY
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
INACTIVE
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
INACTIVE
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
WEAK ACTIVITY
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
ACTIVE
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
EQUIVOCAL
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
WEAK ACTIVITY
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
EQUIVOCAL
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
INACTIVE
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
INACTIVE
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
Periploca forrestii (ASCLEPIADACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
INACTIVE
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
WEAK ACTIVITY
|
|
| 8 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
ACTIVE
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
ACTIVE
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
STRONG ACTIVITY
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
Alangium platanifolium (ALANGIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
STRONG ACTIVITY
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 7 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 8 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 9 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
STRONG ACTIVITY
|
|
| 10 |
RECEPTOR BINDING(BENZODIAZEPINE) DECREASED
| None |
STRONG ACTIVITY
|
|
| 11 |
CALCIUM CHANNEL BINDING EFFECT
| None |
STRONG ACTIVITY
|
|
| 12 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 13 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 14 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 15 |
MUSCARINIC RECEPTOR BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 16 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
STRONG ACTIVITY
|
|
| 17 |
ATP-ASE (NA+/K+) BINDING ACTIVITY
| None |
EQUIVOCAL
|
|
| 18 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
|
| 19 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|
Uncaria rhynchophylla (RUBIACEAE)
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 | Not specified | None | None | |
| 2 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 3 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
ACTIVE
|
|
| 4 |
ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 5 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 6 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 7 |
OPIATE RECEPTOR BINDING INHIBITION
| None |
ACTIVE
|
|
| 8 |
ADENOSINE RECEPTOR BINDING INHIBITION
| None |
WEAK ACTIVITY
|
|
| 9 |
CALCIUM CHANNEL BINDING EFFECT
| None |
ACTIVE
|
|
| 10 |
SULFONYLUREA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 11 |
RECEPTOR BINDING(DOPAMINE) DECREASED
| None |
ACTIVE
|
|
| 12 |
HISTAMINE-1 RECEPTOR BINDING ACTIVITY
| None |
WEAK ACTIVITY
|
|
| 13 |
GABA RECEPTOR BLOCKING EFFECT
| None |
ACTIVE
|
|
| 14 |
GABA RECEPTOR BLOCKING EFFECT
| None |
STRONG ACTIVITY
|